rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Sources of funds
Owner's fund
Equity share capital 1.57 1.57 1.57 1.57 1.57
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 13.85 13.81 13.44 13.01 12.51
Loan funds
Secured loans 8.05 - - - -
Unsecured loans - 6.06 3.58 0.04 0.04
Total 23.46 21.43 18.59 14.61 14.11
Uses of funds
Fixed assets
Gross block 19.04 28.51 26.06 21.38 20.41
Less : revaluation reserve - - - - -
Less : accumulated depreciation - 12.90 11.94 11.20 10.74
Net block 19.04 15.60 14.12 10.17 9.67
Capital work-in-progress - 1.66 1.66 1.64 1.68
Investments 0.05 0.05 0.05 0.04 0.04
Net current assets
Current assets, loans & advances 14.43 11.07 8.27 7.08 5.88
Less : current liabilities & provisions 10.06 6.96 5.51 4.33 3.17
Total net current assets 4.37 4.12 2.76 2.75 2.71
Miscellaneous expenses not written - - - - -
Total 23.46 21.43 18.59 14.61 14.11
Notes:
Book value of unquoted investments - 0.05 0.05 0.04 0.04
Market value of quoted investments - - - - -
Contingent liabilities - - - - -
Number of equity sharesoutstanding (Lacs) 15.66 15.66 15.66 15.66 15.66

Mutual Fund Selector

Find the fund that is right for you
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close